Jaguar Health, Inc. (JAGX)
0.5858
-0.02
(-3.49%)
USD |
NASDAQ |
Feb 12, 16:00
0.5982
+0.01
(+2.12%)
After-Hours: 20:00
Jaguar Health Free Cash Flow : -26.29M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -15.78M |
| Geron Corp. | -132.68M |
| Corvus Pharmaceuticals, Inc. | -32.22M |
| Rapt Therapeutics, Inc. | -86.66M |
| Recursion Pharmaceuticals, Inc. | -450.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.689M |
| Cash from Investing (Quarterly) | -0.054M |
| Cash from Financing (Quarterly) | 6.259M |
| Free Cash Flow Per Share (Quarterly) | -3.134 |
| Free Cash Flow to Equity (Quarterly) | -6.113M |
| Free Cash Flow to Firm (Quarterly) | -4.737M |
| Free Cash Flow Yield | -1.10K% |